SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-18-000478
Filing Date
2018-01-12
Accepted
2018-01-12 16:30:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 posam2018a1_citiuspharma.htm POS AM 886706
2 OPINION OF WYRICK ROBBINS YATES & PONTON LLP posam2018a1ex5-1_citius.htm EX-5.1 6592
3 CONSENT OF WOLF & COMPANY, P.C. posam2018a1ex23-1_citius.htm EX-23.1 3069
4 GRAPHIC image_001.jpg GRAPHIC 5076
  Complete submission text file 0001213900-18-000478.txt   904669
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-217956 | Film No.: 18526266
SIC: 2834 Pharmaceutical Preparations